Finoriq research workspace
Bluejay Diagnostics, Inc. (BJDX) Historical Metrics
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. Review BJDX fundamentals, ratios, and historical filing metrics on Finoriq.
Company Snapshot
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
- Company
- Bluejay Diagnostics, Inc. (BJDX)
- Ticker
- BJDX
- Market Cap
- $1.3M
- Latest Price
- $1.25
- Industry
- Medical Devices
Bluejay Diagnostics, Inc. (BJDX) Current Valuation Metrics
Static valuation preview for Bluejay Diagnostics, Inc. (BJDX). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -473.2% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -442.6% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 0.35x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.